Lennart Erik Jonas Sjögren

Battleriff Gaming AB operates as an entertainment gaming club. The firm offers online games, such as FIFA, league of legends, smite and hearthstone. The company was founded by Mathias Lindmark, Antony Sastre, Elias Löfgren, and Simon Hagert in 2014 and is headquartered in Gothenburg, Sweden.

Delibr AB is a startup based in Stockholm, Sweden that helps product managers and their teams collaborate better in their feature refinement process. The Swedish company offers fair pricing and only charge for active users in the previous month. New users can start with a 14-day free trial without needing to provide credit card information. Nils Janse has been the CEO of the company since 2013.

Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022.

Storytel Sweden AB operates as digital subscription service that stream audiobooks to mobile phone. It also publishes own books under the name Storyside. The company was founded by Jon Hauksson and Per Jonas Tellander in 2005 and is headquartered in Stockholm, Sweden.

Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden.

Vakona is a Swedish company that is developing a new biological drug for the treatment of acne. The drug is based on a bacterial enzyme and has the potential to significantly reduce treatment time and side effects such as skin irritation. The company's research is based on over a decade of work by Dr. Oleg Alexeyev and aims to provide an alternative to the long-term inefficacy of current acne therapies that rely on antibiotics. The company was founded by Oleg Alexeyev and has CEOs Mats Olof Strömqvist and Gabriella Persson.